Yıl: 2010 Cilt: 25 Sayı: 1 Sayfa Aralığı: 12 - 18 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey

Öz:
Amaç: HLA DRB1 ortak epitop alelleri romatoid artritin (RA) en belirgin genetik risk faktörü olup, sınıf 2 HLA molekülünün peptid sunan bölümünde bir amino asit dizilimi tarafından kodlanmaktadır Son zamanlarda bu ortak epitop alellerinin RA'lı hastalarda sitrüllenmiş proteinlere karşı antikorların gelişimi için bir risk faktörü olabileceği öne sürülmektedir. Bu çalışmada Türk toplumundaki RA'lı hastalarda siklik sitrüline peptid antikorları (anti-CCP) pozitifliğinin HLA-DRB1 allellerinin taşıdığı ortak epitopla olan ilişkisi araştırılmıştır.Gereç ve Yöntem: Çalışmaya kliniğimizde yeni tanı konulmuş ya da tedavi altında olan 60 RA'lı hasta dahil edildi. Kontrol grubunu ise 60 sağlıklı gönüllü oluşturdu. RA'lı hastalarda anti-CCP düzeyleri enzim-bağımlı immunosorbent ölçüm metoduyla, HLA-DRB1 tiplemeleri ve OE ölçümü polimeraz zincir reaksiyonu yöntemi ile araştırıldı. Sağlıklı gönüllülerde ise sadece anti-CCP düzeyleri ölçüldü.Bulgular: Romatoid artritli hastalarda OE pozitifliği %50 olarak saptandı ve bu hastaların %30'u çift kopya OE taşıyordu. Anti-CCP pozitifliği RA'lı hastalarda %73.3 iken, kontrol grubunda bu oran %0 olarak saptandı. OE varlığının anti-CCP pozitifliğini arttırdığı (OR=4.3, %95 [CI], P=0.04 ) ve anti-CCP pozitifliği ile RF pozitifliği arasında anlamlı bir ilişkisi olduğu gözlendi (OR=5.3, %95 [CI] P<0.05). Sonuç: Çalışmamızda Türk RA'lı hastalarda OE taşıyan HLA-DRB1 genlerinin anti-CCP üretimiyle anlamlı ilişkisi olduğu ve antiCCP'nin RA için tanısal duyarlılık ve özgüllüğünün sırasıyla %73.3 ve %100 olduğu saptanmıştır.
Anahtar Kelime:

Konular: Romatoloji

Türk Romatoid Artritli Hastalarda Siklik Sitrüline Peptit Antikor Pozitifliği ile HLA-DRB1 Ortak Epitop Alelleri Arasındaki ilişki

Öz:
Objective: The most characteristic genetic risk factors for rheumatoid arthritis (RA), the HLA-DRB1 shared epitope (SE) alleles, encode for a common amino acid sequence in the peptide-presenting part of the HLA class II molecule. These SE alleles have been described recently to be a risk factor for the development of antibodies against citrullinated proteins in RA. The current study was performed to investigate the association between the cyclic citrullinated peptide antibodies (anti-CCP) and HLA-DR1 HLA-DRB1 shared epitope alleles in patients with RA in Turkey.Materials and Methods: Sixty patients with RA who were newly diagnosed or under conventional treatment in our clinic and 60 healthy volunteers as controls were enrolled in the study. In patients with RA anti-CCP levels were investigated with enzymelinked immunosorbent assay and HLA-DRB1 subtyping and SE was assessed by polymerase chain reaction. Only anti-CCP was measured in healthy volunteers.Results: SE was positive in 50% of the patients with RA. Amongst the SE carriers, 30% of them were carrying double copy of SE. While anti-CCP was positive in 73,3% of patients with RA, this ratio was 0% in healthy volunteers. We determined that the existence of SE increases the positivity of anti-CCP (OR=4,3, 95% [CI], P=0.04 ), and a significant relationship was found between the anti-CCP positivity and the RF positivity. (OR=5,3, 95% [CI] P<0.05). Conclusion: The results of the present study revealed that Turkish patients with RA carrying SE with HLA-DRB1 genes is significantly related with the production of anti-CCP. The diagnostic sensitivity and specificity of anti-CCP for RA is determined as 73,3% and 100% respectively.
Anahtar Kelime:

Konular: Romatoloji
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • van Gaalen FA, van Aken J, Huizinga TWJ, Schreuder GM, Breedveld FC, Zanelli E, et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated Peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004; 50: 2113-21. i, Biyok Firestein G.S. (çeviren) Seçkin B ,Başaran P. Romatoid artritin etyoloji ve patogenezi. In: Arasıl T(Çeviri editörü). Kelley Romatoloji. Ankara: Güneş Kitapevi, 2006; 996-1042.
  • Gregersen PK. (çeviren) Gökoğlu F. Yorgancıoğlu R. Romatizmal Hastalıkların Genetiği. In: Arasıl T (Çeviri editörü). Kelley Romatoloji. Ankara: Güneş Kitabevi, 2006; 276-94.
  • Kınıklı G. Romatoid artritli hastalarda tanı ve tedavi yönünden genetik bulguların değerlendirilmesi (proje,2001-K-120210). Ankara: Ankara Üniversitesi 2004; 1-18.
  • Uçar F, Ovalı E, Değer O. MHC gen kompleksi ve HLA doku tiplemesinin testlerinin önemi, İbni Sina Tıp Dergisi 2001; 6: 117-27.
  • Teller K, BudhaiL, Zhang M, Haramati N, Keiser HD, Davidson A. HLA-DRB1 and DQB typing of Hispanic American Patients with rheumatoid arthritis: The 'shared epitope' hypothesis may not apply. J Rheumatol 1995; 23: 1363-8.
  • McDanie DO, Alarcon GS, Prat PW, Reveille JD. Most Africanamerican patients do not have the rheumatoid antigenic determinant (epitope). Ann Intern Med 1995; 123: 181-7.
  • Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005; 52: 3433-8.
  • Zendman AJ, van Venrooij WJ, Pruijin GJ. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 20-5.
  • Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ, et al. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLADRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 2004; 6: R303-8.
  • Cantagrel A, Constantin A, Vincent C, Abbal M, Laroche M, Ohayon E, et al. Rheumatoid factor and antikeratin antibody are independent from presence of DR4 or DR1 in rheumatoid arthritis. Rev Rhum Engl 1999; 66: 20-3.
  • Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000; 2: 236-43.
  • Bas S, Perneger TV, Mikhnevitch E, Seitz M, Tiercy JM, Roux- Lombard P, et al. Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis. Rheumatology 2000; 39: 1082-8.
  • Correa PA, Tobon GJ, Citera G, Cadena J, Schneeberger E, Camargo JF, et al. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1. Biomedica 2004; 24: 140-52.
  • Bongi SM, Porfirio B, Rombolà G. Shared-epitope HLA- DRB1 alleles and sex ratio in Italian patients with rheumatoid arthritis. Joint Bone Spine 2004; 71: 24-8.
  • Kaltenhäuser S. Piere M. Arnold S. Kamprad M, Baerwald C, Häntzschel H. Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis. Rheumatology (Oxford) 2007; 46: 100-4.
  • Ruiz-Morales JA, Vargas-Alarcón G, Flores-Villanueva PO, Villarreal-Garza C, Hernández-Pacheco G, Yamamoto- Furusho JK, et al. HLA-DRB1 alleles encoding the "shared epitope" are associated with susceptibility to developing rheumatoid arthritis whereas HLA-DRB1 alleles encoding an aspartic acid at position 70 of the beta-chain are protective in Mexican Mestizos. Hum Immunol 2004; 65: 262-9.
  • Ioannidis J. Tarassi K, Papadopoulos IA, Voulgari PV, Boki KA, Papasteriades CA, et al. Shared epitopes and rheumatoid arthritis: Disease associations in Greece and meta-analysis of Mediterranean European populations. Semin Arthritis Rheum 2002;31: 361-70.
  • van der Helm-van Mil AH, Verpoort KN, le Cessie S, Huizinga TW, de Vries RR, Toes RE.The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006; 54: 1117-21.
  • Vander Cruyssen B, Peene I, Cantaert T, Cantaert T, Hoffman IE, De Rycke L, et al. Anti-citrullinated protein/ peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor. Autoimmun Rev 2005; 4: 468-74.
  • de Vries RR, Huizinga TW, Toes RE. HLA and RA revisited: citrullinated food for the SE hypothesis, the DR6 effect, and NIMA.Hum Immunol 2006; 67: 454-9.
  • Morel J, Combe B. How to predict prognosis in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2005; 19: 137-46.
  • Vallbracht I, Rieber J, Oppermann M, Förger F, Siebert U, Helmke K, et al. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 2004; 63: 1079-84.
  • Tampoia M, Brescia V, Fontana A, Maggiolini P, Zucano A, Pansini N. Proteomic: new advances in the diagnosis of rheumatoid arthritis. Clin Chim Acta 2005; 357: 219-25.
  • Vossenaar ER., van Venrooij WJ. Anti-CCP antibodies, a highly spesifik marker for (early) rheumatoid arthritis. Clinical and Applied Immunology Reviews 2004; 4: 239-62.
  • Bell DA. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis? J Rheumatol 2006; 33: 2369-71.
  • Berglin E, Johansson T, Sundin U. Jidell E, Wadell G, Hallmans G,et al Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis 2006; 65: 453-8.
  • Irigoyen P, Lee AT, Wener MH, Li W, Kern M, Batliwalla F, et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contri, Biyokasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 2005; 52: 3813-8.
  • Koca SS, Akbulut H, Dag S. Artas H, Isik A. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis and Behçet's disease. Tohoku J Exp Med 2007; 213: 297-304.
APA DAYAN İ, TIKIZ C, TANELİ F, Ulman C, ULUTAŞ G, TÜZÜN Ç (2010). Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey. , 12 - 18.
Chicago DAYAN İdris,TIKIZ CANAN,TANELİ FATMA,Ulman Cevval,ULUTAŞ Gürol,TÜZÜN Çiğdem Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey. (2010): 12 - 18.
MLA DAYAN İdris,TIKIZ CANAN,TANELİ FATMA,Ulman Cevval,ULUTAŞ Gürol,TÜZÜN Çiğdem Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey. , 2010, ss.12 - 18.
AMA DAYAN İ,TIKIZ C,TANELİ F,Ulman C,ULUTAŞ G,TÜZÜN Ç Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey. . 2010; 12 - 18.
Vancouver DAYAN İ,TIKIZ C,TANELİ F,Ulman C,ULUTAŞ G,TÜZÜN Ç Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey. . 2010; 12 - 18.
IEEE DAYAN İ,TIKIZ C,TANELİ F,Ulman C,ULUTAŞ G,TÜZÜN Ç "Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey." , ss.12 - 18, 2010.
ISNAD DAYAN, İdris vd. "Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey". (2010), 12-18.
APA DAYAN İ, TIKIZ C, TANELİ F, Ulman C, ULUTAŞ G, TÜZÜN Ç (2010). Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey. Turkish Journal of Rheumatology(.)Archives of Rheumatology, 25(1), 12 - 18.
Chicago DAYAN İdris,TIKIZ CANAN,TANELİ FATMA,Ulman Cevval,ULUTAŞ Gürol,TÜZÜN Çiğdem Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey. Turkish Journal of Rheumatology(.)Archives of Rheumatology 25, no.1 (2010): 12 - 18.
MLA DAYAN İdris,TIKIZ CANAN,TANELİ FATMA,Ulman Cevval,ULUTAŞ Gürol,TÜZÜN Çiğdem Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey. Turkish Journal of Rheumatology(.)Archives of Rheumatology, vol.25, no.1, 2010, ss.12 - 18.
AMA DAYAN İ,TIKIZ C,TANELİ F,Ulman C,ULUTAŞ G,TÜZÜN Ç Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey. Turkish Journal of Rheumatology(.)Archives of Rheumatology. 2010; 25(1): 12 - 18.
Vancouver DAYAN İ,TIKIZ C,TANELİ F,Ulman C,ULUTAŞ G,TÜZÜN Ç Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey. Turkish Journal of Rheumatology(.)Archives of Rheumatology. 2010; 25(1): 12 - 18.
IEEE DAYAN İ,TIKIZ C,TANELİ F,Ulman C,ULUTAŞ G,TÜZÜN Ç "Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey." Turkish Journal of Rheumatology(.)Archives of Rheumatology, 25, ss.12 - 18, 2010.
ISNAD DAYAN, İdris vd. "Relationship Between Cyclic Citrullinated Peptide Antibodies Positivity and HLA-DRB1 Shared Epitope Alleles in Patients with Rheumatoid Arthritis in Turkey". Turkish Journal of Rheumatology(.)Archives of Rheumatology 25/1 (2010), 12-18.